SARS-CoV-2 Vaccination in Patients with Cancer and COVID-19 in Mexico
Vaccination significantly reduced hospital admissions in patients with STs. Infections occurring during the Omicron period were associated with improved outcomes in both ST and HM patients. Despite having a lesser impact in immunosuppressed patients, vaccination is an essential strategy, and access to vaccination campaigns in patients with cancer needs to be prioritized.
Authors
- Alexandra Martin‐Onraët (ORCID: https://orcid.org/0000-0002-8627-404X)
- Rodrigo Villaseñor-Echavarri (ORCID: https://orcid.org/0000-0001-5750-884X)
- Corazón Barrientos-Flores (ORCID: https://orcid.org/0000-0002-7449-5961)
- Diana Vilar‐Compte (ORCID: https://orcid.org/0000-0001-8564-8735)
- Nancy Martínez-Rivera (ORCID: https://orcid.org/0000-0002-7569-8365)
Institutions
- Instituto Nacional de Cancerología (MX)
Publication Details
- Journal
- Vaccines
- Published
- 2024-10-12
- DOI
- https://doi.org/10.3390/vaccines12101163
- Citations
- 2
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.57